In response to Yaribeygi et al. "Sodium‐glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways"-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In response to Yaribeygi et al. "Sodium‐glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways"

Published:2019-01-29 Issue:7 Volume:234 Page:9906-9907
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

León Jiménez David¹^ORCID,Moreno Obregón Fernando²,Miramontes González José Pablo³

Affiliation:

1. Medicina Interna. Hospital Universitario Virgen Rocío de Sevilla Sevilla Spain

2. Atención Primaria, Centro de Salud Adoratrices Huelva Spain

3. Medicina Interna, Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca Salamanca Spain

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.28235

Reference16 articles.

1. Familial renal glucosuria: SLC5A2 mutation analysis and evidence of salt-wasting

2. Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus

3. Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes

4. Renin-Angiotensin System in Phlorhizin Compared with Alloxan Diabetes in the Rat

5. Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP